Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
(Primer estudio clnico piloto del uso de BPC-157 en humanos: 12 pacientes con cistitis intersticial recibieron 10 mg de BPC-157 va intravesical
A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice
Researchers believe additional biological mechanisms contribute to these health benefits
According to the UK SmPC, treatment typically begins with 0.25 mg once weekly for four weeks, then increases to 0.5 mg, with further increases to 1 mg or 2 mg as tolerated and clinically indicated
For terminal cancer patients where conventional options are exhausted, carefully considered use under medical supervision might be justified despite theoretical tumor promotion risks
US$ 20.80
US$ 24.27
US$ 21.64
US$ 27.59
US$ 25.96
US$ 26.77
